NCT07103902

Brief Summary

The purpose of this study is to examine the acute effects of exercise on cognitive flexibility and symptom reactivity. The main questions it aims to answer are: Does moderate intensity physical activity reduce subjective distress, compulsive urges, and intrusions- and increase cognitive flexibility- in adults with obsessive-compulsive disorder compared to low-intensity physical activity? Researchers will compare low- to moderate-intensity exercise to see if moderate physical activity increases cognitive flexibility and reduces symptom reactivity in adults with obsessive-compulsive disorder (OCD). Participants will: Complete self-report surveys, psychiatric interviews, and cognitive tasks. Be assigned to either a low- or moderate-intensity exercise condition and complete physical activity. Repeat cognitive and symptom measures following the exercise intervention.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Dec 2025Sep 2026

First Submitted

Initial submission to the registry

July 24, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 5, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

November 10, 2025

Status Verified

July 1, 2025

Enrollment Period

9 months

First QC Date

July 24, 2025

Last Update Submit

November 6, 2025

Conditions

Keywords

Anxiety DisordersMental DisordersObsessive-Compulsive Disorder

Outcome Measures

Primary Outcomes (3)

  • Cognitive flexibility will be assessed using a probabilistic reversal learning (PRL) task called the Lucky Picture Selection Game.

    Cognitive flexibility will be initially measured on day 1. Follow-up administrations will be completed 7-10 days later after the exercise intervention during session 2.

  • Symptom reactivity will be assessed using the Braga Obsessive Compulsive Symptom Image Set (BOCI).

    Symptom reactivity will be initially measured on day 1. Follow-up administrations will be completed 7-10 days later after the exercise intervention during session 2.

  • Exercise intensity will be measured using a PolarTech chest-strap HR monitor.

    Exercise intensity will be measured as a function of maximum heart rate (70% Max HR for moderate intensity condition and 40-50% max heart rate for low intensity condition).

    Exercise intensity will be measured during 7-10 days after baseline, during session 2.

Study Arms (2)

Moderate-Intensity Exercise

EXPERIMENTAL
Behavioral: Moderate-Intensity Exercise

Low-Intensity Exercise

OTHER

Control

Behavioral: Low-Intensity Exercise

Interventions

Participants will engage in 20 minutes of cycling at approximately 70% max heart rate with a 2.5 minute warm up and a 2.5 minute cool down.

Moderate-Intensity Exercise

Participants will engage in 20 minutes of cycling at approximately 40-50% max heart rate with a 2.5 minute warm up and a 2.5 minute cool down.

Low-Intensity Exercise

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adults, age 18 to 64 years
  • Meet diagnostic criteria for OCD (per the DIAMOND)
  • Stable psychiatric or medication treatment (if ≥4-weeks), or if no active treatment. Psychotropic medications will be reviewed with the study psychiatrist on a case by case basis.

You may not qualify if:

  • Active or unmanaged psychotic disorders, pervasive developmental disorders, bipolar disorder, current substance use disorder (moderate-to-severe), or high risk for suicide (defined as attempt, plan, or intent within past 3 months)
  • Documented motor impairments and medical condition(s) that prohibit physical exercise
  • Those who are pregnant or trying to become pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Temple Medical Center

New Haven, Connecticut, 06511, United States

Location

MeSH Terms

Conditions

Obsessive-Compulsive DisorderAnxiety DisordersMental Disorders

Central Study Contacts

Emily Weiss, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 24, 2025

First Posted

August 5, 2025

Study Start

December 1, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

November 10, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

Raw, de-indentified data.

Time Frame
IPD will be shared within one year of study completion.
Access Criteria
Access to IPD will be made available upon request.

Locations